يعرض 2,261 - 2,280 نتائج من 18,320 نتيجة بحث عن 'significantly ((((((lower decrease) OR (a decrease))) OR (nn decrease))) OR (teer decrease))', وقت الاستعلام: 0.77s تنقيح النتائج
  1. 2261

    Amplitude for A/L = 0.338. حسب Muhammad Hammad Bucha (21736111)

    منشور في 2025
    "…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …"
  2. 2262

    Amplitude for A/L = 0.02. حسب Muhammad Hammad Bucha (21736111)

    منشور في 2025
    "…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …"
  3. 2263

    Amplitude for A/L = 0.03. حسب Muhammad Hammad Bucha (21736111)

    منشور في 2025
    "…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …"
  4. 2264

    Cohort characteristics. حسب Vincent Pey (21433304)

    منشور في 2025
    "…</p><p>Results</p><p>Upon initiation of CPB we observed a significant decrease in arterial whole blood redox potential (101.90 mV + /- 11.52 vs. 41.80 mV + /- 10,26; p < 0.0001). …"
  5. 2265

    Genes show significant expression change in meta-analysis and their connection with Sjogren’s syndrome and thyroid cancer. حسب Fanyong Kong (20700261)

    منشور في 2025
    "…A gene in red indicates significantly increased expression in the meta-analysis, whereas a gene in blue indicates significantly decreased expression in the meta-analysis.…"
  6. 2266
  7. 2267
  8. 2268

    Table 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.doc... حسب Yiping Cao (1229856)

    منشور في 2024
    "…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …"
  9. 2269

    Image 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif حسب Yiping Cao (1229856)

    منشور في 2024
    "…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …"
  10. 2270

    Image 2_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif حسب Yiping Cao (1229856)

    منشور في 2024
    "…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …"
  11. 2271

    Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis حسب Lin Y.-T. (17065287)

    منشور في 2025
    "…After transitioning to HD, body weight decreased significantly, with a reduction of -2.8 kg at one month, -5.3 kg at three months, and -7.5 kg one year post-transition. …"
  12. 2272
  13. 2273

    Annual number of outpatient visits in all eyes. حسب Yasuyuki Sotani (20114144)

    منشور في 2025
    "…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …"
  14. 2274
  15. 2275
  16. 2276

    Annual treatment frequencies in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

    منشور في 2025
    "…<p>In the recurrence group, the respective treatment counts for anti-VEGF, STTA, MA-PC, PPV, and total treatments (mean ± standard deviation) in the year before surgery were 3.0 ± 1.4, 0.1 ± 0.3, 0.8 ± 1.0, 0.1 ± 0.3, and 4.0 ± 2.1, respectively. These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …"
  17. 2277
  18. 2278
  19. 2279
  20. 2280